Architecture of cancer-associated fibroblasts in tumor microenvironment: mapping their origins, heterogeneity, and role in cancer therapy resistance
The tumor stroma, a key component of the tumor microenvironment (TME), is a key
determinant of response and resistance to cancer treatment. The stromal cells, extracellular …
determinant of response and resistance to cancer treatment. The stromal cells, extracellular …
New target DDR1: A “double-edged sword” in solid tumors
Y Tian, F Bai, D Zhang - Biochimica et Biophysica Acta (BBA)-Reviews on …, 2023 - Elsevier
Globally, cancer is a major catastrophic disease that seriously threatens human health.
Thus, there is an urgent need to find new strategies to treat cancer. Among them, identifying …
Thus, there is an urgent need to find new strategies to treat cancer. Among them, identifying …
Identification of key tumor stroma-associated transcriptional signatures correlated with survival prognosis and tumor progression in breast cancer
MN Uddin, X Wang - Breast Cancer, 2022 - Springer
Background The aberrant expression of stromal gene signatures in breast cancer has been
widely studied. However, the association of stromal gene signatures with tumor immunity …
widely studied. However, the association of stromal gene signatures with tumor immunity …
Pan-cancer analysis reveals homologous recombination deficiency score as a predictive marker for immunotherapy responders
C Yang, Z Zhang, X Tang, X Zhang, Y Chen, T Hu… - Human cell, 2022 - Springer
The immune context of the tumor microenvironment (TME) is critical for effective
immunotherapy. Nonetheless, DNA-based biomarkers for the immune-sensitive TME and …
immunotherapy. Nonetheless, DNA-based biomarkers for the immune-sensitive TME and …
Targeting the ubiquitin signaling cascade in tumor microenvironment for cancer therapy
Q Liu, B Aminu, O Roscow, W Zhang - International journal of molecular …, 2021 - mdpi.com
Tumor microenvironments are composed of a myriad of elements, both cellular (immune
cells, cancer-associated fibroblasts, mesenchymal stem cells, etc.) and non-cellular …
cells, cancer-associated fibroblasts, mesenchymal stem cells, etc.) and non-cellular …
Electrochemotherapy: An alternative strategy for improving therapy in drug-resistant SOLID tumors
M Condello, G D'Avack, EP Spugnini, S Meschini - Cancers, 2022 - mdpi.com
Simple Summary Chemotherapy is becoming an increasingly difficult antitumor therapy to
practice due to the multiple mechanisms of drug resistance. To overcome the problem, it is …
practice due to the multiple mechanisms of drug resistance. To overcome the problem, it is …
Current advances in modulating tumor hypoxia for enhanced therapeutic efficacy
Z Liu, X Liu, W Zhang, R Gao, H Wei, CY Yu - Acta Biomaterialia, 2024 - Elsevier
Hypoxia is a common feature of most solid tumors, which promotes the proliferation,
invasion, metastasis, and therapeutic resistance of tumors. Researchers have been …
invasion, metastasis, and therapeutic resistance of tumors. Researchers have been …
[HTML][HTML] Baicalin and baicalein in modulating tumor microenvironment for cancer treatment: A comprehensive review with future perspectives
Cancer is a leading cause of death worldwide. The burden of cancer incidence and mortality
is increasing rapidly. New approaches to cancer prevention and treatment are urgently …
is increasing rapidly. New approaches to cancer prevention and treatment are urgently …
Interleukins (cytokines) as biomarkers in colorectal cancer: Progression, detection, and monitoring
Cancer is the primary cause of death in economically developed countries and the second
leading cause in developing countries. Colorectal cancer (CRC) is the third most common …
leading cause in developing countries. Colorectal cancer (CRC) is the third most common …
[HTML][HTML] Prostate cancer bone metastases biology and clinical management
E Archer Goode, N Wang… - Oncology Letters, 2023 - spandidos-publications.com
Prostate cancer (PCa) is one of the most prominent causes of cancer‑related mortality in the
male population. A highly impactful prognostic factor for patients diagnosed with PCa is the …
male population. A highly impactful prognostic factor for patients diagnosed with PCa is the …